Perspectives du marché et point de vue des analystes :
La BPCO est une maladie à long terme qui provoque une inflammation pulmonaire, endommage le tissu pulmonaire et entraîne un rétrécissement du voies respiratoires, ce qui rend la respiration difficile. La taille du marché des appareils pour la BPCO s’étend avec l’augmentation des activités de R&D visant à développer des inhalateurs intelligents pour le traitement de la BPCO, le nombre croissant de cas de BPCO et le soutien croissant du gouvernement au traitement de la BPCO. En outre, la disponibilité de produits avancés par les acteurs du marché stimule encore davantage la croissance du marché. Par exemple, en juin 2021, Glenmark Pharma a lancé l'inhalateur de poudre sèche de bromure de tiotropium, utilisé pour traiter la BPCO au Royaume-Uni.
Moteurs de croissance et défis :
La BPCO est une maladie pulmonaire chronique qui provoque une inflammation des poumons, entraînant une obstruction du flux d'air provenant des poumons. Les symptômes de la BPCO comprennent des difficultés respiratoires, une production de mucus (expectorations), une toux et une respiration sifflante. Elle est généralement causée par une exposition à long terme à des gaz ou à des particules irritants, le plus souvent provenant de la fumée de cigarette. Les personnes souffrant de BPCO courent un risque accru de développer un cancer du poumon, une maladie cardiaque et diverses autres affections. Selon l'American Lung Association, la BPCO est la principale cause de décès aux États-Unis, et plus de 12 millions d'Américains ont reçu un diagnostic de ces maladies en 2022. Selon la même source, environ 8,5 millions d'adultes dans le monde ont reçu un diagnostic de BPCO en 2019-2020. . Selon l’Organisation mondiale de la santé (OMS), en 2021, la BPCO était la troisième cause de décès dans le monde. Le taux de mortalité élevé de la BPCO est dû à des exacerbations aiguës, qui conduisent à une insuffisance des muscles respiratoires du patient, entraînant une perte de la capacité du patient à respirer de manière indépendante ; en conséquence, les patients meurent d’une infection systémique et d’une asphyxie. En outre, selon le rapport BOLD (Burden of Obstructive Lung Disease), en 2020, la mortalité due à la BPCO devrait augmenter dans le monde entier au cours des 40 prochaines années, pour atteindre environ 5,4 millions de décès par an d'ici 2060. La prévalence croissante de La BPCO à l'échelle mondiale alimente la croissance du marché des appareils pour la BPCO.
Aperçus stratégiques
Segmentation et portée du rapport :
Le marché des appareils pour la BPCO est segmenté en fonction du type de produit, de la tranche d'âge, du canal de distribution et de la géographie. Le marché des appareils pour la BPCO, par type, est segmenté en inhalateur et nébuliseur. Le marché des appareils pour la BPCO, par tranche d’âge, est segmenté en 20 à 40 ans, 41 à 65 ans, 66 à 80 ans et 85 ans et plus. Le marché des appareils pour la BPCO, par canal de distribution, est segmenté en pharmacies hospitalières, pharmacies de détail et pharmacies en ligne. Sur la base de la géographie, le marché des appareils BPCO est classé en Amérique du Nord (États-Unis, Canada et Mexique), Europe (Royaume-Uni, Allemagne, France, Italie, Espagne et reste de l'Europe), Asie-Pacifique (Chine, Australie, Japon, Inde). , Corée du Sud et reste de l'Asie-Pacifique), Moyen-Orient et Afrique (EAU, Arabie Saoudite, Afrique du Sud et reste du Moyen-Orient et Afrique) et Amérique du Sud et centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale ).
Analyse segmentaire :
Le marché des appareils pour la BPCO, par type de produit, est divisé en inhalateurs et nébuliseurs. En 2022, le segment des inhalateurs détenait une part de marché plus importante et devrait enregistrer un TCAC plus élevé au cours de la période de prévision. Les inhalateurs-doseurs (MDI) et les inhalateurs de poudre sèche (DPI) sont deux principaux types d'inhalateurs utilisés pour traiter la BPCO. Contrairement aux autres inhalateurs qui fournissent une bouffée de médicament, ces inhalateurs contiennent le médicament sous forme de poudre sèche. Le patient doit inspirer rapidement et profondément pour que le médicament pénètre dans les poumons. Les inhalateurs de poudre sèche sont des alternatives cliniquement appropriées et rentables. Les inhalateurs doseurs (MDI) sont des systèmes d'inhalation portatifs sous pression qui fournissent directement de petites doses précises de médicament aux voies respiratoires d'un patient. Les dispositifs MDI comprennent une valve et un actionneur qui facilitent l'administration constante d'une dose précise de médicament au patient sous forme de particules d'une distribution de taille exacte délivrées via un propulseur. Ces inhalateurs nécessitent des gaz propulseurs dont la pression de vapeur peut être liquéfiée à des températures comprises entre 40 et 70 psi à l'intérieur de la cartouche. Les carburants utilisés dans ces inhalateurs-doseurs pour l'inhalation de médicaments doivent être certifiés par la Food and Drug Administration. Cela devrait impliquer la qualité d'inhalation actuelle des bonnes pratiques de fabrication (cGMP) avec des niveaux de pureté élevés.
Marché des appareils pour la BPCO, par type de produit – 2022 et 2030
Analyse régionale :
Sur la base de la géographie, le marché des appareils pour la BPCO est classé en Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient et Afrique, et Sud et Amérique centrale. L’Amérique du Nord est le plus grand contributeur à la croissance du marché mondial des appareils pour la BPCO. En outre, l’Asie-Pacifique devrait enregistrer le TCAC le plus élevé sur le marché mondial des appareils pour la BPCO au cours de la période de prévision. La croissance future de ce marché sera probablement attribuée à la prévalence croissante des troubles respiratoires. En outre, la maladie pulmonaire obstructive chronique (MPOC) constitue un fardeau majeur pour la santé aux États-Unis. La BPCO est causée par une obstruction du flux d’air provenant des poumons, ce qui peut entraîner une maladie pulmonaire inflammatoire chronique. Le tabagisme est l'une des principales causes de BPCO aux États-Unis. La préférence croissante pour le tabagisme aux États-Unis stimule la croissance du marché des appareils pour la BPCO. Selon les Centers for Disease Control and Prevention (CDC), environ 14,8 millions d'adultes aux États-Unis souffrent de BPCO.
En outre, selon l'Administration for Community Living, les personnes âgées de 65 ans et plus aux États-Unis représentaient 54,1 millions. , qui représente 16 % de la population totale, et devrait atteindre 21,6 % d’ici 2040. Les personnes âgées sont extrêmement sensibles aux maladies respiratoires chroniques. Ainsi, une augmentation de la population âgée devrait également stimuler la demande d’inhalateurs respiratoires au cours de la période de prévision. De plus, des politiques de remboursement favorables devraient créer plusieurs opportunités pour la croissance du marché des appareils pour la BPCO dans la région.
Développements de l'industrie et opportunités futures :
Divers plans des principaux acteurs opérant sur le marché des appareils pour la BPCO sont répertoriés ci-dessous :
En avril 2022, GlaxoSmithKline Pharmaceuticals Limited a lancé Trelegy Ellipta (furoate de fluticasone/umeclidinium/vilanterol) en Inde. Il s'agit de la première trithérapie à inhalateur unique (SITT) pour les patients atteints de BPCO dans le cadre d'un régime une fois par jour. Le produit a également été approuvé par le Drugs Controller General of India (DCGI) pour la consommation de Trelegy Ellipta comme traitement d'entretien pour prévenir et soulager les symptômes liés à la BPCO chez les patients âgés de 18 ans et plus. Paysage concurrentiel et entreprises clés :
Quelques Les principaux acteurs opérant sur le marché des dispositifs contre la BPCO sont AstraZeneca PLC, Beximco Pharmaceuticals Ltd, Getinge AB, Boehringer Ingelheim, GSK Plc, Medtronic PLC, Nephron Pharmaceuticals, Novartis AG, Sunovion Pharmaceuticals Inc et Teva Pharmaceuticals. Ces sociétés se concentrent sur l'expansion géographique et le lancement de nouveaux produits pour répondre à la demande croissante des consommateurs mondiaux et élargir leur gamme de produits dans des portefeuilles spécialisés. Leur présence mondiale leur permet de servir une large base de clients, facilitant ainsi l'expansion du marché.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The COPD devices market majorly consists of the players such AstraZeneca PLC, Beximco Pharmaceuticals Ltd, Getinge AB, Boehringer Ingelheim, GSK Plc, Medtronic PLC, Nephron Pharmaceuticals, Novartis AG, Sunovion Pharmaceuticals Inc, and Teva Pharmaceuticals
Chronic obstructive pulmonary disease, or COPD, refers to a group of diseases that cause airflow blockage and breathing-related problems. It includes emphysema and chronic bronchitis. In people with COPD, the lungs can get damaged or clogged with phlegm. Symptoms include cough, sometimes with phlegm, difficulty breathing, wheezing and tiredness. Smoking and air pollution are the most common causes of COPD. People with COPD are at higher risk of other health problems.According to Centers for Diseases Control and Prevention (CDC), COPD makes breathing difficult for the 16 million Americans who have this disease. everal inhalation device types are available, including metered-dose inhalers (MDIs), dry-powder inhalers (DPIs), soft mist inhalers (SMIs), and small volume nebulizers (SVNs). Each of these devices has unique attributes to consider when selecting treatment for a specific patient.
The increasing cases of COPD, and strategic initiatives in COPD devices bolster the COPD devices market size. However, the high cost associated with COPD devices hinders the COPD devices market growth.
Based on geography, the COPD devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global COPD devices market. Asia Pacific is expected to register the highest CAGR in the COPD devices market during 2022–2030.
The COPD devices market, by product type, is bifurcated into inhaler and nebulizer. In 2022, the inhaler segment held a larger market share, and it is expected to record a higher CAGR during the forecast period. The COPD devices market, by distribution channel, is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2022, the retail pharmacies segment held the largest market share; moreover, the same segment is expected to record the highest CAGR during the forecast period. Online pharmacies are the fastest-growing distribution channel of the COPD devices market.
The List of Companies - COPD Devices Market
- AstraZeneca PLC
- Beximco Pharmaceuticals Ltd
- Getinge AB
- Boehringer Ingelheim
- GSK Plc
- Medtronic PLC
- Nephron Pharmaceuticals
- Novartis AG
- Sunovion Pharmaceuticals Inc
- Teva Pharmaceuticals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jan 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jan 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jan 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jan 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)